Drug Search Results
More Filters [+]


Alternative Names: carteolol, teoptic, cartrol, ocupress
Latest Update: 2016-01-05
Latest Update Note: Clinical Trial Update

Product Description

Carteolol is used alone or together with other medicines to treat increased pressure in the eye that is caused by open-angle glaucoma or a condition called intraocular (in the eye) hypertension. This medicine is a beta-blocker . (Sourced from: https://www.mayoclinic.org/drugs-supplements/carteolol-ophthalmic-route/side-effects/drg-20070992?p=1)

Mechanisms of Action: ADRB1 Antagonist,ADRB2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Ophthalmic

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Belgium | Brazil | Chile | China | Colombia | Czech | Egypt | France | Hong Kong | India | Indonesia | Ireland | Italy | Japan | Jordan | Korea | Luxembourg | Morocco | Netherlands | Pakistan | Peru | Poland | Portugal | Romania | Saudi Arabia | Slovakia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carteolol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events